Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Trial Type:  Treatment
Treatment/Intervention:  gene therapy
Results 1-15 of 15 for your search:
Start Over
Immunotherapy Combination Study in Advanced Previously Treated Non-Small Cell Lung Cancer
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: NLG0401, NCI-2016-00186, 1504-1393, NCT02460367
Cyclophosphamide and Vaccine Therapy With or Without Trastuzumab in Treating Patients With Stage IV Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: J0947, NCI-2010-02004, NA_00024527, JHOC-J0947, GENENTECH-JHOC-J0947, NCT00971737
Vaccine Therapy after Donor Stem Cell Transplant in Treating Patients with Advanced Myelodysplastic Syndrome or Acute Myeloid Leukemia
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 12-217, NCI-2013-00286, NCT01773395
Immunotherapy Study for Patients With Stage IV Melanoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: NLG0304, NCI-2014-00700, 1303-1217, NCT02054520
Phase II Study of Combined Temozolomide and SGT-53 for Treatment of Recurrent Glioblastoma
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: SGT53-02-2, NCI-2015-00561, NCT02340156
Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to External-Beam Radiation Therapy
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: MC0252, NCI-2009-01195, 06-009392, MAYO-MC0252, NCT00788307
Oncolytic HSV1716 in Treating Patients with Refractory Non-Central Nervous System Solid Tumors
Status: Active
Phase: Phase I
Type: Treatment
Age: 13 to 30
Trial IDs: OSU-08196, NCI-2016-00251, IRB13-00471, NCT00931931
Oncolytic HSV-1 rRp450 in Treating Patients with Primary Liver Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 09-042, NCI-2010-01930, NCT01071941
Gene-Modified T Cells in Treating Patients with Metastatic Prostate Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 09-036, NCI-2010-01408, NCT01140373
Gene Therapy for Fanconi Anemia
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: Not specified
Trial IDs: 2097.00, NCI-2011-00202, NCT01331018
Combined Cytotoxic and Immune-Stimulatory Strategy in Treating Patients with High-Grade Glioma That Can Be Removed by Surgery
Status: Active
Phase: Phase I
Type: Treatment
Age: 18 to 75
Trial IDs: UMCC 2015.024, NCI-2015-02157, HUM00057130, CR00047519, NCT01811992
Viral Therapy In Treating Patients with Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Cancer or Metastatic Breast Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: MC0979, NCI-2013-00811, NCT01846091
A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 75
Trial IDs: ATI001-102, NCI-2014-00752, NCT02026271
Safety and Efficacy of Intra-Arterial Ad-p53 in Liver Metastases of Colorectal Cancer
Status: Active
Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: MultiVir Ad-p53, NCI-2016-01271, NCT02842125
Gene Therapy after Frontline Chemotherapy in Treating Patients with AIDS-Related Non-Hodgkin Lymphoma
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 65
Trial IDs: 13282, NCI-2013-01728, 098798, 118843, 112240, NCT01961063
Start Over